High throughput methods to characterize protein permeation and release

International Journal of Pharmaceutics

Volumn 350, Issue 1-2, 2008, Pages 272-278

  Capelle, Martinus A H ^a   Gurny, Robert ^a   Arvinte, Tudor ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Drug release; High throughput screening; Hirudin; Permeability; Protein formulation

Indexed keywords

AGAR; BOVINE SERUM ALBUMIN; HIRUDIN; TYROSINE;

ARTICLE; COOLING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLUORESCENCE; MEMBRANE TRANSPORT; PH; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; ROOM TEMPERATURE; SPECTROSCOPY;

DRUG DELIVERY SYSTEMS; HIRUDINS; PERMEABILITY; PROTEINS; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE;

EID: 38349092953     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.09.007     Document Type: Article

References (17)

1. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46 (2001) 27-43
2. Capelle M.A.H., Gurny R., and Arvinte T. High throughput screening of protein formulation stability: practical considerations. Eur. J. Pharm. Biopharm. 65 (2007) 131-148
3. Castelain C., and Genot C. Conformational changes of bovine serum albumin upon its adsorption in dodecane-in-water emulsions as revealed by front-face steady-state fluorescence. Biochim. Biophys. Acta - Gen. Sub. 1199 (1994) 59-64
4. Cleland J.L., Daugherty A., and Mrsny R. Emerging protein delivery methods. Curr. Opin. Biotechnol. 12 (2001) 212-219
5. Deutsch E., Rao A.K., and Colman R.W. Selective thrombin inhibitors: the next generation of anticoagulants. J. Am. Coll. Cardiol. 22 (1993) 1089-1092
6. Di L., Kerns E.H., Fan K., McConnell O.J., and Carter G.T. High throughput artificial membrane permeability assay for blood-brain barrier. Eur. J. Med. Chem. 38 (2003) 223-232
7. Eckhardt B.M., Oeswein J.Q., Yeung D.A., Milby T.D., and Bewley T.A. A turbidimetric method to determine visual appearance of protein solutions. J. Pharm. Sci. Technol. 48 (1994) 64-70
8. Gietz U., Arvinte T., Mader E., Oroszlan P., and Merkle H.P. Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release model. Eur. J. Pharm. Biopharm. 45 (1998) 259-264
9. Green R.J., Hopkinson I., and Jones R.A.L. Unfolding and intermolecular association in globular proteins adsorbed at interfaces. Langmuir 15 (1999) 5102-5110
10. Irvine J.D., Takahashi L., Lockhart K., Cheong J., Tolan J.W., Selick H.E., and Grove J.R. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Sci. 88 (1999) 28-33
11. Jen A., Madorin K., Vosbeck K., Arvinte T., and Merkle H.P. Transforming growth factor beta-3 crystals as reservoirs for slow release of active TGF-beta3. J. Control Release 78 (2002) 25-34
12. Jorgensen L., Moeller E.H., van de W.M., Nielsen H.M., and Frokjaer S. Preparing and evaluating delivery systems for proteins. Eur. J. Pharm. Sci. 29 (2006) 174-182
13. Jorgensen L., van de W.M., Vermehren C., Bjerregaard S., and Frokjaer S. Probing structural changes of proteins incorporated into water-in-oil emulsions. J. Pharm. Sci. 93 (2004) 1847-1859
14. Kansy M., Avdeef A., and Fischer H. Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists. Drug Discov. Today: Technol. 1 (2004) 349-355
15. Kansy M., Senner F., and Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. 41 (1998) 1007-1010
16. Ruel-Gariepy E., and Leroux J.C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 58 (2004) 409-426
17. Wohnsland F., and Faller B. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J. Med. Chem. 44 (2001) 923-930